• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病的表型表达与心脏磁共振延迟钆增强

Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.

作者信息

Caetano Francisca, Botelho Ana, Trigo Joana, Silva Joana, Almeida Inês, Venâncio Margarida, Pais João, Sanches Conceição, Leitão Marques António

机构信息

Serviço de Cardiologia, Hospital Geral, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Serviço de Cardiologia, Hospital Geral, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

出版信息

Rev Port Cardiol. 2014 May;33(5):261-7. doi: 10.1016/j.repc.2013.10.005. Epub 2014 Jun 6.

DOI:10.1016/j.repc.2013.10.005
PMID:24909443
Abstract

INTRODUCTION AND AIM

The prognostic value of late gadolinium enhancement (LGE) for risk stratification of hypertrophic cardiomyopathy (HCM) patients is the subject of disagreement. We set out to examine the association between clinical and morphological variables, risk factors for sudden cardiac death and LGE in HCM patients.

METHODS

From a population of 78 patients with HCM, we studied 53 who underwent cardiac magnetic resonance. They were divided into two groups according to the presence or absence of LGE. Ventricular arrhythmias and morbidity and mortality during follow-up were analyzed.

RESULTS

Patients with LGE were younger at the time of diagnosis (p=0.046) and more often had a family history of sudden death (p=0.008) and known coronary artery disease (p=0.086). On echocardiography they had greater maximum wall thickness (p=0.007) and left atrial area (p=0.037) and volume (p=0.035), and more often presented a restrictive pattern of diastolic dysfunction (p=0.011) with a higher E/É ratio (p=0.003) and left ventricular systolic dysfunction (p=0.038). Cardiac magnetic resonance supported the association between LGE and previous echocardiographic findings: greater left atrial area (p=0.029) and maximum wall thickness (p<0.001) and lower left ventricular ejection fraction (p=0.056). Patients with LGE more often had an implantable cardioverter-defibrillator (ICD) (p=0.015). At follow-up, no differences were found in the frequency of ventricular arrhythmias, appropriate ICD therapies or mortality.

CONCLUSIONS

The presence of LGE emerges as a risk marker, associated with the classical predictors of sudden cardiac death in this population. However, larger studies are required to confirm its independent association with clinical events.

摘要

引言与目的

钆延迟增强(LGE)对肥厚型心肌病(HCM)患者进行危险分层的预后价值存在争议。我们旨在研究HCM患者的临床和形态学变量、心源性猝死危险因素与LGE之间的关联。

方法

在78例HCM患者中,我们对53例接受心脏磁共振检查的患者进行了研究。根据是否存在LGE将他们分为两组。分析随访期间的室性心律失常以及发病率和死亡率。

结果

LGE患者诊断时年龄较小(p = 0.046),更常具有心源性猝死家族史(p = 0.008)和已知冠状动脉疾病(p = 0.086)。超声心动图显示,他们有更大的最大壁厚(p = 0.007)、左心房面积(p = 0.037)和容积(p = 0.035),更常表现为舒张功能障碍的限制性模式(p = 0.011),E/A比值更高(p = 0.003)以及左心室收缩功能障碍(p = 0.038)。心脏磁共振支持LGE与先前超声心动图结果之间的关联:更大的左心房面积(p = 0.029)、最大壁厚(p < 0.001)以及更低的左心室射血分数(p = 0.056)。LGE患者更常植入植入式心律转复除颤器(ICD)(p = 0.015)。随访期间,室性心律失常的频率、ICD的适当治疗或死亡率均未发现差异。

结论

LGE的存在成为一种风险标志物,与该人群心源性猝死的经典预测因素相关。然而,需要更大规模的研究来证实其与临床事件的独立关联。

相似文献

1
Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.肥厚型心肌病的表型表达与心脏磁共振延迟钆增强
Rev Port Cardiol. 2014 May;33(5):261-7. doi: 10.1016/j.repc.2013.10.005. Epub 2014 Jun 6.
2
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者对比增强磁共振成像延迟钆增强的特征及临床意义。
Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.
3
Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.心脏磁共振钆延迟增强与肥厚型心肌病的表型表达。
Am Heart J. 2011 Jun;161(6):1073-7. doi: 10.1016/j.ahj.2011.03.022.
4
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
5
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
6
Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.晚期钆增强在肥厚型心肌病且无心脏性猝死临床危险因素的患者中很常见:一项单中心经验。
Cardiol J. 2014;21(1):29-32. doi: 10.5603/CJ.a2013.0115. Epub 2013 Aug 30.
7
[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].[钆延迟强化在肥厚型心肌病患者心血管磁共振成像中的临床意义]
Rev Esp Cardiol. 2007 Jan;60(1):15-23.
8
Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy.磁共振评估的晚期钆增强位置与肥厚型心肌病的心律失常风险。
Rev Port Cardiol (Engl Ed). 2020 Nov;39(11):615-621. doi: 10.1016/j.repc.2019.12.009. Epub 2020 Nov 7.
9
Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy.心脏磁共振成像结果可预测肥厚型心肌病的主要不良事件。
J Thorac Imaging. 2014 Nov;29(6):331-9. doi: 10.1097/RTI.0000000000000115.
10
Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.心脏磁共振成像心肌纤维化严重程度可预测肥厚型心肌病的持续性心律失常事件。
Can J Cardiol. 2013 Mar;29(3):358-63. doi: 10.1016/j.cjca.2012.05.004. Epub 2012 Jun 30.

引用本文的文献

1
Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?肥厚型心肌病患者心脏性猝死的预防:指南有哪些变化?
Arq Bras Cardiol. 2018 Jun;110(6):524-531. doi: 10.5935/abc.20180099.